A cutting-edge animal vaccine manufacturing facility will also be constructed.
Animal healthcare in Abu Dhabi will take a massive gallop forward after it was announced that two state-of-the-art animal hospitals will be constructed.
The hospitals will be a part of a new animal health platform that will also comprise a cutting-edge animal vaccine manufacturing facility.
A joint venture between ADQ, an Abu Dhabi-based investment and holding company, and E20 Investment, an agribusiness investment company in the UAE, will further enhance the emirate’s position as a regional leader in high-end veterinary services for horses and camels while producing the most technologically advanced animal vaccines serving the Middle East and Africa (MEA) region.
Fahad Al Qassim, Executive Director, Healthcare & Life Sciences Portfolio at ADQ, said; “Leveraging our healthcare and life sciences expertise, we have identified an opportunity to create an adjacent platform in animal health.
“By creating a joint venture with E20, we will capitalise on Abu Dhabi’s strong market potential for animal vaccine production and maintaining the health and welfare of prized animals, such as horses and camels.”
Sultan Al Jaberi, CEO of E20 Investment Limited, added; “Together with ADQ, we will bring world-class vaccine technology to the UAE and join hands with our partner to foster local production and serve lucrative markets in the MENA region and beyond.”
For all the latest news, follow Yalla UAE